Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease

There is notable disparity between symptomatology and disease activity in a significant proportion of patients with inflammatory bowel disease (IBD), and escalation of treatment based on symptoms alone can fail to significantly alter the course of disease. The STRIDE-II position statement, published...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Jack, Tan, Katrina, Devi, Jalpa, Macrae, Finlay, Christensen, Britt, Segal, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573216/
https://www.ncbi.nlm.nih.gov/pubmed/37834936
http://dx.doi.org/10.3390/jcm12196292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573216/
https://www.ncbi.nlm.nih.gov/pubmed/37834936
http://dx.doi.org/10.3390/jcm12196292

Ejemplares similares